Stephen Tomlinson to Melanoma, Experimental
This is a "connection" page, showing publications Stephen Tomlinson has written about Melanoma, Experimental.
Connection Strength
0.105
-
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. Blood. 2012 Jun 21; 119(25):6043-51.
Score: 0.090
-
Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice. Cancer Res. 2006 Jun 15; 66(12):6258-63.
Score: 0.015